TCBX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TCBX is not a good buy right now for an impatient buyer. The chart is bullish, but there are no Intellectia buy signals today and insider selling has surged (+550% last month), which materially weakens the near-term setup. With price already near the pivot (40.03) and approaching first resistance (41.98), the risk/reward for an immediate entry is only moderate versus limited confirmed catalysts.
Trend/structure: Bullish. The moving averages are stacked positively (SMA_5 > SMA_20 > SMA_200), signaling an established uptrend. Momentum: MACD histogram is positive (0.147) and expanding, supporting continuation. RSI(6) at ~60.9 is neutral-to-mildly bullish (not overbought). Levels: Pivot 40.03 (price is slightly above at 40.56). Near-term resistance at R1 41.98, then R2 43.18. Supports at S1 38.09 and S2 36.89. Pattern-based outlook: Modeled probabilities imply mild weakness over the next day/week (-1.73% next day, -0.23% next week) but stronger 1-month upside potential (+25.84%), suggesting the bigger move may require time and/or a better entry.
Intellectia Proprietary Trading Signals
with solid YoY growth in revenue, net income, and EPS.
Insiders are selling aggressively (selling amount up 550.08% over the last month), a notable bearish sentiment indicator.
No news/catalysts in the past week to drive an immediate breakout.
Near-term resistance overhead around ~41.98; short-horizon pattern stats lean slightly negative for the next day/week.
Hedge funds are neutral (no supportive accumulation signal).
Latest quarter: 2025/Q4. Revenue grew to $56.25M (+22.11% YoY). Net income rose to $16.70M (+33.21% YoY). EPS increased to $0.95 (+31.94% YoY). Overall, growth trends are strong and supportive of the longer-term bull case.
Recent change: On 2026-01-26, Keefe Bruyette raised the price target to $45 from $43 while keeping a Market Perform rating. Wall Street view: Pros—rising price target and strong recent earnings growth support upside. Cons—Market Perform (not a bullish upgrade) suggests expectations are balanced rather than high-conviction, aligning with the current mixed near-term setup.
